Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer.
about
The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patientsSystemic Inflammatory Response Based on Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker in Bladder CancerC-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewClinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-AnalysisAssociation between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric CancerThe pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study.Analysis of the Fibrinogen and Neutrophil-Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and PrognosisModified glasgow prognostic score as a prognostic factor in gastriccancer patients: a systematic review and meta-analysisPreoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancerNomogram based on systemic inflammatory response markers predicting the survival of patients with resectable gastric cancer after D2 gastrectomy.Inflammation-related factors predicting prognosis of gastric cancer.Prognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studies.Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients.Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma.Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.Association between the inflammatory biomarker, C-reactive protein, and the response to radiochemotherapy in patients with esophageal cancerDoes the modified Glasgow Prognostic Score (mGPS) have a prognostic role in esophageal cancer?Role of Prealbumin as a Powerful and Simple Index for Predicting Postoperative Complications After Gastric Cancer Surgery.Which is a more reliable indicator of survival after gastric cancer surgery: Postoperative complication occurrence or C-reactive protein elevation?Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan-prognostic assessment tools validation (J-ProVal) study.Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma.Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysisPreoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer.Preoperative indicators of the systemic inflammatory response in the treatment of patients with gastrointestinal cancer.Is the Glasgow Prognostic Score Applicable to Both Early- and Advanced-Stage Gastric Cancers?Prognostic Significance of Serum Inflammatory Markers in Gastric Cancer.The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks.The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China.Serum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer.The plasma levels of 12 cytokines and growth factors in patients with gastric cancer.TNM-PNI: a novel prognostic scoring system for patients with gastric cancer and curative D2 resectionNeutrophil-to-lymphocyte ratio after four weeks of nivolumab administration as a predictive marker in patients with pretreated non-small-cell lung cancerPretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma
P2860
Q21131782-9CE8FB78-5DE5-48A1-9BE3-0DD5368211E0Q26765951-46C4C816-813B-4C70-8D2C-00C0503E097AQ26771557-63CC0017-3C91-4147-A1BD-218054DC2019Q26828549-53C5363C-6A0E-40C9-9B27-879B682A32C3Q35071202-E51FF765-B5F3-4BBD-B951-D5FF673B5452Q35609756-E3EF83B0-3F2B-442F-8151-78E2E7ED2DFBQ35663782-766F206D-6852-4881-826A-6637B0D34498Q36124168-72CA1539-4CC2-490C-8749-91AB42B678CAQ36207128-84457661-491C-40E8-B068-48BDD2EB31E2Q36317466-09573000-FF2A-495A-8EEE-89A4D743BF1EQ37035451-65DE1C38-758F-4253-A2AF-734CA516E80FQ37437217-64D8FDF0-090E-434F-AC0E-EBFB768BACE9Q37724656-435D11F4-728A-47FF-862F-D41956DB4148Q38369552-CA218346-05AE-46B2-9FAC-F93D7B0BA93AQ38642286-511BDB08-85D8-4DD5-AFA5-5828C1300DB6Q38663037-50314A40-11BC-4E89-BCCB-8B8354A95F2AQ39131387-09EF4129-EC6D-4576-824C-589911385F08Q39655246-FBA1F69C-0D57-4E19-A60C-C93FD25320C9Q39897201-B72E711C-AD1B-4EC4-AC65-AA7232E8D405Q40537176-B9F30E37-90F5-4477-8884-66A0753BA36FQ41232575-602127E8-2A8D-4312-A68F-96878794BFDBQ41427892-AA535EF8-8C3E-4198-A47A-ACFC5C3701A3Q41595498-906B33BD-EC1B-4B04-AA0A-C6CC65716105Q42446178-F64F439F-0535-4E1E-86BC-0E905BEE1EA2Q43143206-62F52133-28B5-48F4-9894-C6FB642EA02BQ46102070-4B568EC0-47CD-4390-BB8E-C1E29C4410BDQ47215342-0A45AC7A-EA83-41B0-BA3B-C4E5319016D4Q47299558-88E9DCBB-7FFE-47A2-88B0-1AFA50EF0494Q47338550-10CB4C5A-62A8-4A96-840E-E8127B891508Q48354896-6871A83D-CF8A-41BD-9308-5B986E5591BCQ53086091-8417FDBE-7816-47AC-802B-DF1D8D425019Q53130326-2DD6FC17-7A41-4360-8E64-1353985A9335Q55379927-9BF1EF81-2233-4D87-B03D-4013871E37AEQ58698557-6C695A0B-1B3A-44F1-A52F-6CB4B719BB72Q58732737-741ABD91-4789-4C2A-BC2C-F0000ACB26E3Q58803497-91967DCD-1980-4476-8E97-DD20C3CA69EA
P2860
Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Prognostic importance of the i ...... patients with gastric cancer.
@ast
Prognostic importance of the i ...... patients with gastric cancer.
@en
type
label
Prognostic importance of the i ...... patients with gastric cancer.
@ast
Prognostic importance of the i ...... patients with gastric cancer.
@en
prefLabel
Prognostic importance of the i ...... patients with gastric cancer.
@ast
Prognostic importance of the i ...... patients with gastric cancer.
@en
P2093
P2860
P356
P1476
Prognostic importance of the i ...... patients with gastric cancer.
@en
P2093
T Yamaguchi
P2860
P2888
P304
P356
10.1038/BJC.2012.262
P407
P577
2012-06-19T00:00:00Z